Axon Enterprise, Inc. AXON
Set alert
425.43 USD -2.34 -0.55%
At close
426.00 +0.57 +0.13%
Pre-market · Nov 3, 7:21 AM ET
424.82 Day range 439.73
339.01 52-week range 719.92
- YTD
- -25.09%
- 1 year
- -41.25%
- Open
- 435.00
- Prev close
- 427.77
- Mkt cap
- 34.56B
- Vol
- 848.15K
- Avg vol
- 989.62K
- EPS
- 2.41
- P/E
- 176.53
- Div yield
- 0.00%
More statistics
- Low
- 424.82
- High
- 439.73
- Forward P/E
- 40.47
- Beta
- 1.47
- Short ratio
- 3.59
- Inst. own
- 91.22%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 463.44
- 200-d avg
- 478.83
- 1y target
- 680.37
MAX chart
Events in this range
- Aug 4, 2025Earnings: 2.12; estimate 1.45; surprise 46.21%
- Nov 4, 2025Earnings: 1.17; estimate 1.52; surprise -23.03%
- May 6, 2026Earnings: 1.61; estimate 1.6; surprise 0.63%
- Aug 4, 2026Earnings: 1.88; estimate 1.84; surprise 2.17%
- Aug 6, 2026Rating: Piper Sandler · Overweight → Overweight
- Aug 6, 2026Rating: Morgan Stanley · Overweight → Overweight
- Aug 6, 2026Rating: UBS · Neutral → Neutral
- Sep 3, 2026Rating: Argus Research · Buy → Buy
- Nov 5, 2026Earnings: —; estimate 1.89; surprise —%
Signals (99)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| SMA: Bearish | Nov 1, 2025 | 1 year ago |
| MACD: Sell Signal | Nov 1, 2025 | 1 year ago |
| RSI: Overbought | Apr 1, 2025 | 1 year ago |
| RSI: Overbought | Aug 1, 2024 | 2 years ago |
| RSI: Overbought | Feb 1, 2024 | 2 years ago |
| SMA: Bullish | Aug 1, 2023 | 3 years ago |
| SMA: Bearish | Jul 1, 2023 | 3 years ago |
| MACD: Buy Signal | Dec 1, 2022 | 3 years ago |
| SMA: Bullish | Oct 1, 2022 | 4 years ago |
| SMA: Bullish | Oct 1, 2022 | 4 years ago |
| SMA: Bearish | Apr 1, 2022 | 4 years ago |
| SMA: Bearish | Dec 1, 2021 | 4 years ago |
| MACD: Sell Signal | Dec 1, 2021 | 4 years ago |
| RSI: Overbought | Jun 1, 2021 | 5 years ago |
| RSI: Overbought | Apr 1, 2021 | 5 years ago |
Newest 20 of 99.
Analyst view
Consensus: buy
Buy
Price target (mean) 680.37 +59.9% upside
Now 425.43
- Target (low)
- 440.00
- Target (mean)
- 680.37
- Target (high)
- 830.00
Ratings (0m) 21 18 buy · 3 hold · 0 sell
- Strong buy8
- Buy10
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 21
- 1 month ago 21
- 2 months ago 21
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.89 | 1.22 – 2.46 | 1.17 | +61.6% | 936.95M | +31.9% | 18 |
| Next quarter | 2.29 | 1.47 – 2.84 | 2.15 | +6.6% | 1.06B | +33.6% | 18 |
| Current year | 7.64 | 6.19 – 8.80 | 6.85 | +11.5% | 3.71B | +33.4% | 20 |
| Next year | 10.51 | 7.72 – 12.05 | 7.64 | +37.6% | 4.80B | +29.5% | 20 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 26, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 20, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Sep 3, 2026 | Argus Research | Maintained | Buy | Buy |
| Aug 6, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 6, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 6, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 13, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 6, 2026 | Needham | Maintained | Buy | Buy |
| Jun 25, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| May 8, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 7, 2026 | UBS | Maintained | Neutral | Neutral |
| May 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 7, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| May 7, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Apr 16, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Apr 13, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Apr 8, 2026 | TD Cowen | Maintained | Buy | Buy |
| Apr 8, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Feb 25, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 25, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 25, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Feb 25, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 25, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 20, 2026 | Needham | Maintained | Buy | Buy |
| Dec 17, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 17, 2025 | RBC Capital | Initiated | — | Outperform |
| Nov 6, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 5, 2025 | UBS | Maintained | Neutral | Neutral |
| Nov 5, 2025 | Goldman Sachs | Maintained | Buy | Buy |
